Jason M. Mallory

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

Julio Rosenstock, Antonio Nino, Joseph Soffer et al. · Diabetes Care · 2020 · 67 citations · Full text

Carnitine/Acylcarnitine Translocase Deficiency (Neonatal Phenotype): Successful Prenatal and Postmortem Diagnosis Associated with a Novel Mutation in a Single Family

Bing-Zhi Yang, Jason M. Mallory, Diane S. Roe et al. · Molecular Genetics and Metabolism · 2001 · 36 citations

Developmental Anomaly, Neonatal Phenotype, Neonatology +8

Albiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trials

Bo Åhrén, Molly C. Carr, Karen Murphy et al. · Diabetes Research and Clinical Practice · 2017 · 25 citations

Diabetes Management, Harmony Phase 3, Medicine +6

Gastrointestinal safety across the albiglutide development programme

LA Leiter, Jason M. Mallory, T. H. Wilson et al. · Diabetes Obesity and Metabolism · 2016 · 13 citations

Adverse Events, Diabetes Management, Gastrointestinal Pharmacology +10